Molecular Mechanisms of Viral Immune Evasion Proteins to Inhibit MHC Class I Antigen Processing and Presentation

被引:13
|
作者
Zhou, Fang [1 ]
机构
[1] Univ Queensland, Princess Alexandra Hosp, Diamantina Inst Canc Immunol & Metab Med, Brisbane, Qld 4102, Australia
关键词
viral immune evasion protein; MHC class I antigen presentation; IFN-gamma; JAK/STAT signal transduction pathway; CTL epitope; IRF-1; MAJOR HISTOCOMPATIBILITY COMPLEX; PEPTIDE-LOADING COMPLEX; UBIQUITIN-CONJUGATING ENZYME; INTERFERON REGULATORY FACTOR; SIMPLEX-VIRUS TYPE-1; TRANS-GOLGI NETWORK; DOUBLE-STRANDED-RNA; INFLUENZA-B VIRUS; CELL-CYCLE ARREST; KINASE PKR;
D O I
10.1080/08830180903013034
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Viral products inhibit MHC class I antigen processing and presentation via three major pathways: inhibition of major histocompatibility complex WHO class I expression on cells, blockade of peptide trafficking and loading on MHC class I molecules, and inhibition of peptide generation in host cells. Viral products also interfere with IFN-gamma-mediated JAK/STAT signal transduction in cells. These results imply that viral proteins probably inhibit the function of IFN-gamma in MHC class I antigen presentation via inactivation of JAK/STAT signal transduction in host cells. Mechanisms of viral products to inhibit IFN-gamma-mediated MHC class I antigen presentation were summarized in this literature review.
引用
收藏
页码:376 / 393
页数:18
相关论文
共 50 条
  • [21] Mechanisms of MHC class I-restricted antigen processing and cross-presentation
    Cresswell, P
    Ackerman, AL
    Giodini, A
    Peaper, DR
    Wearsch, PA
    IMMUNOLOGICAL REVIEWS, 2005, 207 : 145 - 157
  • [22] Mechanisms of MHC class I - Restricted antigen processing
    Pamer, E
    Cresswell, P
    ANNUAL REVIEW OF IMMUNOLOGY, 1998, 16 : 323 - 358
  • [23] Molecular Mechanisms of MHC Class I-Antigen Processing: Redox Considerations
    Kim, Youngkyun
    Kang, Kwonyoon
    Kim, Ilkwon
    Lee, Yoon Jeong
    Oh, Changhoon
    Ryoo, Jeongmin
    Jeong, Eunae
    Ahn, Kwangseog
    ANTIOXIDANTS & REDOX SIGNALING, 2009, 11 (04) : 907 - 936
  • [24] ANTIGEN PROCESSING FOR PRESENTATION BY MHC CLASS-I MOLECULES
    BRACIALE, TJ
    CURRENT OPINION IN IMMUNOLOGY, 1992, 4 (01) : 59 - 62
  • [25] New insights into the structure of the MHC class I peptide-loading complex and mechanisms of TAP inhibition by viral immune evasion proteins
    Praest, Patrique
    Liaci, A. Manuel
    Forster, Friedrich
    Wiertz, Emmanuel J. H. J.
    MOLECULAR IMMUNOLOGY, 2019, 113 : 103 - 114
  • [26] Delivery by Trypanosoma cruzi of proteins into MHC class I antigen processing and presentation pathway.
    Garg, N
    Nunes, M
    Tarleton, RL
    FASEB JOURNAL, 1996, 10 (06): : 110 - 110
  • [27] Molecular mechanisms of class I major histocompatibility complex antigen processing and presentation
    Yang, Y
    Sempe, P
    Peterson, PA
    IMMUNOLOGIC RESEARCH, 1996, 15 (03) : 208 - 233
  • [28] Virus evasion of MHC class I molecule presentation
    Petersen, JL
    Morris, CR
    Solheim, JC
    JOURNAL OF IMMUNOLOGY, 2003, 171 (09): : 4473 - 4478
  • [29] An Evolutionarily Conserved Function of Polycomb Silences the MHC Class I Antigen Presentation Pathway and Enables Immune Evasion in Cancer
    Burr, Marian L.
    Sparbier, Christina E.
    Chan, Kah Lok
    Chan, Yih-Chih
    Kersbergen, Ariena
    Lam, Enid Y. N.
    Azidis-Yates, Elizabeth
    Vassiliadis, Dane
    Bell, Charles C.
    Gilan, Omer
    Jackson, Susan
    Tan, Lavinia
    Wong, Stephen Q.
    Hollizeck, Sebastian
    Michalak, Ewa M.
    Siddle, Hannah, V
    McCabe, Michael T.
    Prinjha, Rab K.
    Guerra, Glen R.
    Solomon, Benjamin J.
    Sandhu, Shahneen
    Dawson, Sarah-Jane
    Beavis, Paul A.
    Tothill, Richard W.
    Cullinane, Carleen
    Lehner, Paul J.
    Sutherland, Kate D.
    Dawson, Mark A.
    CANCER CELL, 2019, 36 (04) : 385 - +
  • [30] Viral interference with MHC class I antigen presentation pathway: The battle continues
    Ambagala, APN
    Solheim, JC
    Srikumaran, S
    VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 2005, 107 (1-2) : 1 - 15